Artemis Medicare Services Limited has announced a hospital visit for investors and analysts scheduled for June 19, 2026. The event will take place in Gurugram and will be conducted in physical mode. The company confirmed that no unpublished price sensitive information will be shared during the interaction.

The disclosure was made to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule is subject to changes in case of exigencies on the part of analysts, investors, or the company.

Event Schedule

The intimation was signed by Poonam Makkar, Company Secretary and Compliance Officer of Artemis Medicare Services Limited.

Artemis Medicare Services Limited will seek shareholder approval to raise funds up to Rs 700 crores through a postal ballot process. The company's board is scheduled to meet on June 4, 2026, to consider and approve the notice for this postal ballot. The fundraising initiative aims to secure capital through one or more tranches via permissible modes, subject to necessary regulatory approvals.

The proposal to raise funds was initially approved by the board during its meeting held on February 2, 2026. The company had disclosed this development to the stock exchanges on the same day. The upcoming meeting on June 4, 2026, will focus on the procedural steps required to facilitate the postal ballot, allowing members to vote on the capital raising plan.

Key Details of the Fundraising Proposal

The postal ballot mechanism is being utilized to secure the consent of the company's members for this significant financial decision. This method allows shareholders who cannot attend a general meeting in person to participate in the voting process. The company must ensure that all procedural requirements under the SEBI Listing Regulations are met before proceeding with the ballot.

Artemis Medicare Services Limited has stated that the funds will be raised subject to the receipt of necessary approvals, indicating that the final execution depends on regulatory clearances and shareholder consent. The company secretary, Poonam Makkar, signed the intimation sent to the exchanges on June 1, 2026.